Brookline Capital Markets is a financial services firm that provides a range of investment banking services, including mergers and acquisitions, capital raising, and financial advisory. The firm focuses on delivering tailored solutions to meet the unique needs of its clients.

Brookline Capital Markets, a division of Arcadia Securities, LLC, provides a comprehensive suite of capital markets and advisory services to cutting-edge public and private emerging growth companies. Brookline seeks opportunities to accelerate growth for its client companies while delivering results to the firm’s sophisticated investor base.

Brookline has significant experience providing the following services:

Pre-IPO Financings
IPOs, Secondaries and PIPEs
Trade Facilitation for Private Equities
Capital Markets Advisory
Strategic Advisory
Equity Research

Brookline differentiates itself through its ability to source capital from traditional institutional investors, as well as from its proprietary network of global family office and high net worth individual investors. For many of the firm’s family office and high net worth clients, Brookline serves as a “curator” of compelling early stage venture and growth equity opportunities. This investor base provides companies access to patient and sophisticated capital.

In addition to Brookline’s unique, non-institutional investor network in the U.S., the firm maintains a significant presence internationally. Investors in recent transactions include funds and wealthy individuals located in Canada, China, Hong Kong, Italy, Korea, and the U.K.

Brookline is led by seasoned investment banking professionals, each with more than 25 years of capital markets and advisory experience at some of the world’s most prominent financial institutions.

Brookline Capital Markets

We would like to congratulate Genelux for its recent successful issuances in the equity capital markets. 

#lifesciences #capitalmarkets

Please see attached for this month's Brookline Brief.

We are very excited to be hosting our Virtual CRISPR Symposium today!

See below for the full agenda:

Please find attached the corresponding cover letter to this month's Brookline Brief.

Please find attached our latest Brookline Brief.

Below, please find the corresponding cover letter for this month's Brookline Brief.

Please see below for this month's edition of the Brookline Brief.

Furthermore, see below for our note recognizing the performance of our our IPO of Genelux Corp. 

We would like to thank our investors for their support and confidence in us as we continue to identify and support companies that have the potential to change the world.

Brookline Capital Markets is proud to recognize the robust performance of the recent Better Therapeutics PIPE Offering.

Please find attached our monthly publication of The Brookline Brief, which describes the current state of the life sciences, med. tech, and diagnostics subsegments of the Equity Capital Markets.

COM:BROOKLINECAPMKTS

Brookline Capital Markets

Analysis Not Available